A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

  • Nguyen, Diana (PI)

Project: Other project

Project Details

StatusFinished
Effective start/end date9/12/199/11/22